Attention Deficit Disorder With Hyperactivity Clinical Trial
Official title:
Reducing ADHD by Promoting Social Collaboration and Self-Regulation Skills
This study will determine the effectiveness of an intervention for preventing at-risk kindergarten and pre-kindergarten children from developing attention deficit hyperactivity disorder.
Attention deficit hyperactivity disorder (ADHD) is characterized by inattention,
impulsiveness, and hyperactivity. ADHD is not commonly diagnosed until a child has entered
formal schooling and shown academic and behavioral adjustment difficulties, but
developmental research suggests that risk factors for developing ADHD are evident earlier. A
significant number of children start school with high levels of disorganized and inattentive
behaviors, which are symptoms of emerging ADHD. This study will test an intervention aimed
at preventing the development of ADHD by identifying those at risk for developing ADHD in
kindergarten and pre-kindergarten and teaching them self-regulation skills through
socialization. These skills have been associated with school success, and they may reduce
the likelihood of children developing ADHD.
Participation in this study will last for 4 months, with a follow-up assessment after 1
year. To enroll, child participants will undergo a screening process that will include
assessments by their teachers and parents. Eligible child participants will also be assessed
by researchers in a classroom setting. They will then be randomly assigned to receive either
a play-based intervention, called the Friendship Group, or an individual pre-academic
tutoring intervention. Both groups will meet at school. The Friendship Group, which will
focus on strengthening attention and self-regulation through social skills, will involve 30
sessions twice a week for 15 weeks. The tutoring intervention, which will focus on
strengthening academic skills, will involve one or two sessions a week for 4 months.
Participants will be assessed at three time points: pre-intervention, post-intervention, and
after 1 year. Assessments will include teacher ratings and direct testing of child
attention, language, and pre-academic skills.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00202605 -
Safety and Efficacy of SPD465 in Adults With ADHD
|
Phase 2 | |
Not yet recruiting |
NCT02677519 -
A 12-Month Open Label Safety Study of Aptensio XR® in Children Ages 4-5 Years Diagnosed With ADHD
|
Phase 4 | |
Completed |
NCT02730572 -
Concerta (Methylphenidate) -To-Generic Switch Study
|
N/A | |
Completed |
NCT01681082 -
Psychological Effects of Tai Chi Training
|
N/A | |
Active, not recruiting |
NCT01330693 -
Cortical Excitability: Phenotype and Biomarker in Attention-deficit, Hyperactivity Disorder (ADHD) Therapy
|
Phase 3 | |
Completed |
NCT00830700 -
Children's Attention Deficit Disorder With Hyperactivity (ADHD) Telemental Health Treatment Study
|
N/A | |
Completed |
NCT01012622 -
An Efficacy and Safety Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention Deficit Hyperactivity Disorder (ADHD)
|
Phase 4 | |
Completed |
NCT00626236 -
Phase 2a Study of Safety and Tolerability of SPN-810 in Children With ADHD and Persistent Serious Conduct Problems
|
Phase 2 | |
Completed |
NCT00598182 -
Adherence and Long-term Effect of OROS Methylphenidate (CONCERTA): A Follow-up Study
|
N/A | |
Completed |
NCT00381407 -
Organizational Skills Training for Children With Attention Deficit Hyperactivity Disorder
|
N/A | |
Completed |
NCT00178503 -
Methylphenidate for Attention Deficit Hyperactivity Disorder and Autism in Children
|
Phase 2/Phase 3 | |
Completed |
NCT00247572 -
Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories
|
Phase 2 | |
Completed |
NCT00218322 -
Effectiveness of ATMX in Treating Adolescents With ADHD and SUD
|
Phase 4 | |
Completed |
NCT00557011 -
NRP104, Adderall XR or Placebo in Children Aged 6-12 Years With ADHD
|
Phase 2 | |
Completed |
NCT00118911 -
Cognitive Behavioral Therapy for Treatment of Adult Attention Deficit Hyperactivity Disorder
|
N/A | |
Completed |
NCT00071656 -
Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I
|
N/A | |
Active, not recruiting |
NCT00057668 -
Preventing Behavior Problems in Children With ADHD
|
Phase 2 | |
Completed |
NCT00050050 -
Cognitive Behavioral Therapy for Adult Attention Deficit Hyperactivity Disorder
|
Phase 1 | |
Completed |
NCT00050622 -
Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD)
|
N/A | |
Completed |
NCT00031395 -
Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in Children
|
Phase 3 |